Axon Enterprise Inc

AXON remains in a Stage 2 advancing uptrend and above the rising 50 DMA, but recent attempts failed to exceed the July high and price has been rejected at the flattened 9 EMA/21 EMA. Short-term momentum is down, making immediate entry unfavorable. We will stalk for a pullback into the short-EMA zone or support at the rising 50 DMA before considering a long execution.

• ↑Q1 2026 revenue reached $807 M (+34% YoY), marking nine quarters above 30% growth
• ↑AI product revenue grew over 700% YoY, driving faster customer adoption
• ↓Negative earnings yield and low book-to-price indicate high valuation risk